Table 3 |
||||||
|
Comparison of Median PGE2 Concentrations in ng/mL in Plasma Based on Celecoxib Dose and Disease Status1 |
||||||
|
Before (N) |
After (N) |
Washout (N) |
P value |
|||
|
|
||||||
|
Before v. After (N) |
After v. Washout (N) |
Before v. Washout (N) |
||||
|
|
||||||
|
Population2 |
||||||
|
High risk |
0.29 (26) |
0.21 (26) |
0.25 (23) |
0.72 (26) |
0.50 (23) |
0.70 (23) |
|
Cancer |
0.37 (13) |
0.30 (12) |
NA |
0.03 (12) |
||
|
P value |
0.16 |
0.99 |
||||
|
|
||||||
|
1: N: sample size; NA: not applicable. 2: Reasons why blood was not collected: In the high risk group at washout, three subjects refused. In the cancer group, one subject refused blood collection after treatment. |
||||||
|
Sauter et al. BMC Cancer 2006 6:248 doi:10.1186/1471-2407-6-248 |
||||||
